K
Kidswell Bio Corporation
TSE:4584
Kidswell Bio Corporation
TSE:4584
Price:
274
JPY
3.4%
Market Cap:
¥13.6B
Balance Sheet
Balance Sheet Decomposition
Kidswell Bio Corporation
Kidswell Bio Corporation
Balance Sheet Decomposition is not available for
Kidswell Bio Corporation
Kidswell Bio Corporation
Balance Sheet
Kidswell Bio Corporation
Kidswell Bio Corporation
Currency: JPY
| Mar-2008 | Mar-2009 | Mar-2010 | Mar-2011 | Mar-2012 | Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Cash & Cash Equivalents |
57
|
168
|
61
|
302
|
286
|
887
|
1 610
|
599
|
817
|
2 380
|
1 891
|
2 009
|
2 033
|
1 461
|
1 187
|
1 067
|
2 231
|
2 995
|
|
| Cash Equivalents |
57
|
168
|
61
|
302
|
286
|
887
|
1 610
|
599
|
817
|
2 380
|
1 891
|
2 009
|
2 033
|
1 461
|
1 187
|
1 067
|
2 231
|
2 995
|
|
| Total Receivables |
0
|
174
|
98
|
120
|
214
|
17
|
149
|
190
|
199
|
587
|
405
|
559
|
652
|
817
|
462
|
1 089
|
881
|
1 317
|
|
| Accounts Receivables |
0
|
163
|
95
|
113
|
207
|
7
|
149
|
190
|
199
|
587
|
405
|
559
|
652
|
817
|
462
|
1 089
|
881
|
1 267
|
|
| Other Receivables |
0
|
11
|
3
|
7
|
7
|
10
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
50
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
12
|
254
|
451
|
989
|
635
|
876
|
1 475
|
|
| Other Current Assets |
1
|
1
|
1
|
7
|
6
|
15
|
123
|
303
|
504
|
455
|
396
|
241
|
384
|
618
|
688
|
906
|
936
|
913
|
|
| Total Current Assets |
58
|
342
|
159
|
428
|
505
|
919
|
1 882
|
1 092
|
1 520
|
3 422
|
2 692
|
2 822
|
3 322
|
3 346
|
3 326
|
3 697
|
4 924
|
6 701
|
|
| PP&E Net |
2
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
2
|
2
|
2
|
1
|
2
|
3
|
2
|
1
|
1
|
1
|
|
| PP&E Gross |
2
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
2
|
2
|
2
|
1
|
2
|
3
|
2
|
1
|
1
|
1
|
|
| Accumulated Depreciation |
5
|
6
|
6
|
6
|
6
|
6
|
6
|
5
|
5
|
6
|
6
|
6
|
121
|
11
|
12
|
7
|
8
|
8
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
2
|
2
|
1
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
50
|
165
|
276
|
325
|
323
|
249
|
563
|
155
|
173
|
138
|
283
|
|
| Other Long-Term Assets |
0
|
2
|
2
|
2
|
2
|
2
|
4
|
4
|
6
|
6
|
6
|
6
|
19
|
19
|
18
|
21
|
20
|
23
|
|
| Total Assets |
60
N/A
|
346
+473%
|
162
-53%
|
431
+166%
|
508
+18%
|
922
+82%
|
1 887
+105%
|
1 147
-39%
|
1 694
+48%
|
3 706
+119%
|
3 025
-18%
|
3 151
+4%
|
3 592
+14%
|
3 934
+10%
|
3 503
-11%
|
3 895
+11%
|
5 086
+31%
|
7 008
+38%
|
|
| Liabilities | |||||||||||||||||||
| Accounts Payable |
20
|
85
|
59
|
46
|
94
|
0
|
0
|
0
|
69
|
0
|
60
|
57
|
9
|
110
|
45
|
156
|
85
|
227
|
|
| Accrued Liabilities |
1
|
1
|
2
|
2
|
3
|
4
|
4
|
5
|
6
|
6
|
6
|
8
|
0
|
0
|
0
|
1
|
1
|
14
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
460
|
0
|
0
|
0
|
25
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
350
|
0
|
0
|
0
|
0
|
0
|
75
|
375
|
737
|
657
|
|
| Other Current Liabilities |
3
|
30
|
13
|
63
|
64
|
21
|
46
|
88
|
395
|
184
|
338
|
335
|
847
|
1 005
|
1 008
|
524
|
1 552
|
3 421
|
|
| Total Current Liabilities |
23
|
116
|
73
|
112
|
161
|
25
|
50
|
92
|
1 280
|
189
|
405
|
400
|
881
|
1 114
|
1 129
|
1 056
|
2 375
|
4 319
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
775
|
775
|
0
|
0
|
0
|
0
|
1 200
|
1 100
|
625
|
1 575
|
1 838
|
1 181
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
0
|
89
|
0
|
0
|
0
|
56
|
|
| Other Liabilities |
3
|
3
|
5
|
5
|
6
|
10
|
9
|
9
|
11
|
15
|
15
|
19
|
24
|
20
|
31
|
30
|
41
|
41
|
|
| Total Liabilities |
26
N/A
|
119
+355%
|
78
-34%
|
117
+50%
|
167
+43%
|
34
-79%
|
834
+2 324%
|
876
+5%
|
1 291
+47%
|
206
-84%
|
421
+104%
|
420
0%
|
2 105
+401%
|
2 324
+10%
|
1 785
-23%
|
2 661
+49%
|
4 254
+60%
|
5 598
+32%
|
|
| Equity | |||||||||||||||||||
| Common Stock |
110
|
350
|
350
|
604
|
778
|
1 240
|
1 571
|
1 576
|
2 037
|
4 194
|
100
|
591
|
612
|
1 032
|
1 421
|
1 509
|
2 037
|
2 318
|
|
| Retained Earnings |
89
|
376
|
519
|
797
|
1 118
|
1 495
|
1 993
|
2 785
|
3 573
|
4 795
|
872
|
1 726
|
9 020
|
9 962
|
10 429
|
11 091
|
12 548
|
12 658
|
|
| Additional Paid In Capital |
13
|
253
|
253
|
507
|
681
|
1 143
|
1 475
|
1 480
|
1 940
|
4 098
|
3 373
|
3 864
|
9 917
|
10 338
|
10 727
|
10 815
|
11 342
|
11 623
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
3
|
2
|
22
|
203
|
0
|
0
|
0
|
128
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
34
N/A
|
227
+563%
|
84
-63%
|
314
+273%
|
341
+9%
|
888
+160%
|
1 053
+19%
|
271
-74%
|
403
+49%
|
3 500
+768%
|
2 604
-26%
|
2 731
+5%
|
1 487
-46%
|
1 610
+8%
|
1 719
+7%
|
1 234
-28%
|
831
-33%
|
1 411
+70%
|
|
| Total Liabilities & Equity |
60
N/A
|
346
+473%
|
162
-53%
|
431
+166%
|
508
+18%
|
922
+82%
|
1 887
+105%
|
1 147
-39%
|
1 694
+48%
|
3 706
+119%
|
3 025
-18%
|
3 151
+4%
|
3 592
+14%
|
3 934
+10%
|
3 503
-11%
|
3 895
+11%
|
5 086
+31%
|
7 008
+38%
|
|
| Shares Outstanding | |||||||||||||||||||
| Common Shares Outstanding |
2
|
3
|
3
|
4
|
5
|
8
|
10
|
10
|
12
|
19
|
19
|
20
|
28
|
30
|
31
|
32
|
39
|
44
|
|
Switch to:
Switch to:
See Also
Discover More
